- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01748474
Effect of Short-term Oxygen During CPET in Pulmonary Hypertension (ExOx-CPET)
August 11, 2016 updated by: University of Zurich
Effect of Short-term Oxygen Therapy on Cardiopulmonary Exercise Capacity in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
In a randomized, sham-controlled trial the investigators will test whether supplemental oxygen given during cardiopulmonary exercise testing will improve exercise performance and physiological parameters in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8091
- University Hospital Zurich, Division of Pneumology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
- diagnosis of pulmonary arterial hypertension class I and IV (according to the latest WHO classification scheme of Dana Point 2008)
- on optimized medical therapy and in stable condition for at least 4 week
- desaturate in the 6 minute walking test by at least 4% to values <92%
Exclusion criteria:
- unstable conditions
- pregnant women
- patients with pulmonary venous hypertension
- patients with relevant concomitant lung disease and severe daytime hypoxemia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Supplemental oxygen
Supplemental oxygen will be applied via a mask during CPET
|
|
Placebo Comparator: Sham room air
Room air will be applied similarly to oxygen
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Watt
Time Frame: 1 day
|
1 day
|
exercise time
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in arterial blood parameters
Time Frame: 1 day
|
1 day
|
Peak oxygen uptake
Time Frame: 1 day
|
1 day
|
Respiratory exchange ratio
Time Frame: 1 day
|
1 day
|
ventilatory equivalent of carbon dioxide (VE/VCO2) slope
Time Frame: 1 day
|
1 day
|
end-tidal pressures of carbon dioxide (PET CO2)
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Silvia Ulrich Somaini, MD, University Hospital Zurich, Division of Pneumology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2012
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
July 1, 2016
Study Registration Dates
First Submitted
October 4, 2012
First Submitted That Met QC Criteria
December 11, 2012
First Posted (Estimate)
December 12, 2012
Study Record Updates
Last Update Posted (Estimate)
August 12, 2016
Last Update Submitted That Met QC Criteria
August 11, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KEK-ZH-NR. 2012-0251
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
-
University of ZurichCompletedPulmonary Arterial and Chronic Thromboembolic Pulmonary HypertensionSwitzerland
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Heidelberg UniversityMerck Sharp & Dohme LLCRecruitingChronic Thromboembolic Pulmonary Hypertension | Primary Pulmonary Arterial HypertensionGermany
-
Pulmonary Hypertension Association, Inc.University of Washington, the Collaborative Health Studies Coordinating CenterRecruitingPulmonary Arterial Hypertension | Pulmonary Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited States
-
SciPharm SàRLCompletedNon-operable Chronic Thromboembolic Pulmonary HypertensionAustria, Poland, Czechia, Germany
-
University of ZurichCompletedPulmonary Hypertension | Pulmonary Artery Hypertension | Chronic Thromboembolic Pulmonary HypertensionSwitzerland
-
Assistance Publique - Hôpitaux de ParisMerck Sharp & Dohme LLCRecruitingPulmonary Embolism | Chronic Thromboembolic Pulmonary Hypertension (CTEPH)France
-
Polish Cardiology AssociationJagiellonian UniversityRecruitingPulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionPoland
-
ActelionEPS Corporation; Imepro Inc.; General Laboratory, BML, Inc.; Mitsubishi Logistics...TerminatedChronic Thromboembolic Pulmonary Hypertension (CTEPH)Japan
-
University of California, San DiegoE Squared Trials and Registries, Inc.CompletedPulmonary Hypertension | Chronic Thromboembolic Pulmonary Hypertension (CTEPH)United States
Clinical Trials on Supplemental oxygen via a mask
-
Santa Clara Valley Health & Hospital SystemCompletedSurgical Site InfectionUnited States
-
Washington University School of MedicineBarnes-Jewish HospitalCompletedSurgical Wound Infection | Endometritis | Infection; Cesarean SectionUnited States
-
Vyaire MedicalM.D. Anderson Cancer CenterCompleted
-
University of South FloridaUniversity of PadovaCompletedFibromyalgia | Interstitial Cystitis
-
Vanderbilt University Medical CenterRevolutionary Medical Devices, Inc.CompletedVentilation | Colonoscopy | OxygenationUnited States
-
University of New MexicoCompleted
-
Mahidol UniversityCompleted
-
University of VirginiaONY; LMA North AmericaTerminatedRespiratory Distress Syndrome, NewbornUnited States
-
Dr. David Yuen Chung CHANRecruitingChronic Subdural HematomaHong Kong